The most common TKI-sensitizing mutations in the EGFR are deletions in exon 19 that affect the LREA motif and substitutions in exon 21 (L858R), which together account for more than 90% of all EGFR mutations in lung adenocarcinoma (LA) (2). The gene discussed is EGFR; the disease is lung adenocarcinoma.